Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stoke Therapeutics (STOK) Return on Equity (2022 - 2025)

Stoke Therapeutics has reported Return on Equity over the past 4 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Equity at 0.02% for Q4 2025, up 37.0% from a year ago — trailing twelve months through Dec 2025 was 0.02% (up 37.0% YoY), and the annual figure for FY2025 was 0.02%, up 43.0%.
  • Return on Equity for Q4 2025 was 0.02% at Stoke Therapeutics, down from 0.13% in the prior quarter.
  • Over the last five years, Return on Equity for STOK hit a ceiling of 0.17% in Q1 2025 and a floor of 0.72% in Q1 2024.
  • Median Return on Equity over the past 4 years was 0.5% (2023), compared with a mean of 0.34%.
  • Biggest five-year swings in Return on Equity: fell -23bps in 2024 and later soared 90bps in 2025.
  • Stoke Therapeutics' Return on Equity stood at 0.52% in 2022, then dropped by -21bps to 0.63% in 2023, then surged by 39bps to 0.39% in 2024, then soared by 95bps to 0.02% in 2025.
  • The last three reported values for Return on Equity were 0.02% (Q4 2025), 0.13% (Q3 2025), and 0.15% (Q2 2025) per Business Quant data.